Myestin 60mg Tablet
Marketer
Vhb Life Sciences Inc
Salt Composition
Pyridostigmine (60mg)
Overview Myestin 60mg Tablet
Neostigmine 60mg tablets are indicated for managing myasthenia gravis (a condition causing muscle fatigue and weakness), paralytic ileus (intestinal muscle paralysis), and post-surgical urinary retention. This medication enhances muscle strength, facilitates bowel regularity, and stimulates bladder function. Administer Neostigmine 60mg tablets on an empty stomach, consistently at the same time daily, as prescribed by your physician, completing the entire course. Omit doses only upon consultation. Abrupt cessation is strongly discouraged. Potential side effects include nausea, hypersalivation, diarrhea, blurred vision, dyspnea, lacrimation, abdominal discomfort, and altered micturition frequency. Additional possible effects are diaphoresis, cephalalgia, rhinorrhea, and pyrosis. Drowsiness and vertigo may occur; avoid activities requiring alertness, such as driving. Prior to commencing treatment, disclose any pre-existing renal impairment, Parkinson's disease, asthma, or gastrointestinal issues. Monitor blood pressure for potential hypotension; consult your doctor if needed. Maintain adequate hydration due to the potential for diarrhea. Consult your physician regarding pregnancy, pregnancy planning, or breastfeeding.
Uses of Myestin 60mg Tablet
Managing myasthenia gravis, paralytic ileus, and postoperative urinary retention.
Major Benefits of Myestin 60mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Myestin 60mg tablets on an empty stomach.
Common Side effects of Myestin 60mg Tablet:
- Nausea
- Excessive salivation
- Diarrhea
- Blurred vision
- Breathlessness
- Watery eyes
- Abdominal pain
- Altered frequency of urination
- Sweating
- Headache
- Dizziness
- Runny nose
- Heartburn
- Gastro-esophageal reflux disease
- Paresthesia (tingling or pricking sensation)
- Muscle twitching
- Weakness
- Muscle cramp
- Increased bronchial secretions
How to use Myestin 60mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Myestin 60mg Tablet on an empty stomach.
How Myestin 60mg Tablet works:
Myestin 60mg tablets boost acetylcholine, a neurotransmitter, facilitating improved nerve-muscle signal transmission.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Myestin 60mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Myestin 60mg tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Myestin 60mg tablets appear compatible. Preliminary data from human studies indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Taking a 60mg Myestin tablet can cause drowsiness, blurred vision, and dizziness. Operating a vehicle or machinery is unsafe under these conditions. Impaired visual acuity, a potential side effect of Myestin 60mg tablets, necessitates avoidance of driving or operating machinery.
KidneyCAUTION
Individuals with impaired kidney function should use Myestin 60mg tablets with careful monitoring. Dosage modification for Myestin 60mg tablets may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Myestin 60mg Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Myestin 60mg Tablet :
Should you forget a Myestin 60mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Myestin 60mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyridinium N-Methyl Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Carbamate cholinesterase inhibitors |




